6505-01-363-0935 ( NDC00300-3626-28 , LUPRON )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-363-0935 | 6505 | 013630935 | LEUPROLIDE ACETATE INJECTION KIT | 3804 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| AJJW | COMPONENT QUANTITY | 43 |
| AJCN | PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND ANTINEOPLASTIC DRUG AND SUBJECT TO DAMAGE BY FREEZING |
| FEAT | SPECIAL FEATURES | STERILE; AQUEOUS SOLUTION; 5 MG. LEUPROLIDE ACETATE PER ML. |
| AJKD | NONSUPPLY ITEMS AND QUANTITIES | 2.8 ML. MILTI-DOSE VIAL 1; 0.5 ML. HYPODERMIC,DISPOSABLE SYRINGES 14; INDIVIDUALLY FOIL WRAPPED ALCOHOL WIPES 28 |
| ALCD | USAGE DESIGN | FOR USE IN THE TREATMENT OF PROSTATIC CANCER |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00300-3626-28 | 49476 | A | 2 | 3 | 6 | 54 | |
| LUPRON | 49476 | A | 1 | 3 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00300-3626-28 | 49476 | TAP PHARMACEUTICAL PRODUCTS INC | A | A |
| LUPRON | 49476 | TAP PHARMACEUTICAL PRODUCTS INC | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| U | X | A | 1 | 08/21/1 | P | 3004909115 | 3804 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | U | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 0 | KT | S | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|